Skip to main content

Triglide FDA Approval History

FDA Approved: Yes (First approved May 7, 2005)
Brand name: Triglide
Generic name: fenofibrate
Dosage form: Tablets
Company: SkyePharma PLC
Treatment for: Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa, Elevated LDL, Hyperlipoproteinemia Type IIb, Elevated LDL VLDL, Hyperlipoproteinemia Type IV, Elevated VLDL, Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL, Hypertriglyceridemia

Triglide (fenofibrate) is a lipid-regulating agent for the treatment of hypercholesterolemia and hypertriglyceridemia.

Development timeline for Triglide

May  7, 2005Approval Triglide SkyePharma PLC - Treatment for Lipid Disorders

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.